Clinical trial
An Open-label Trial of Glivec in Patients With Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors Expressing C-kit.
NCT00293124 is registered in ClinicalTrials.gov with Central European Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Trial of Glivec in Patients With Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors Expressing C-kit.
- Lead sponsor
- Central European Cooperative Oncology Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- July 31, 2008
- Enrollment
- 125 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.